Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: Results of an 18-month follow-up study in Ouagadougou, Burkina Faso

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 22, Issue 7, 2010, Pages 843-850

  Kouanda, Seni ^a   Tougri, Halima ^a   Cissé, Mireille ^b   Simporé, Jacques ^c   Pietra, Virginio ^c   Doulougou, Boukaré ^a   Ouédraogo, Gautier ^a   Ouédraogo, Charlemagne Marie ^d   Soudré, Robert ^d   Sondo, Blaise ^a  

^a Centre National de la Recherche Scientifique et Technologique   (Burkina Faso)

^b UNICEF   (United States)

^c CERBA ^*  (Burkina Faso)

^d UNIVERSITÉ DE OUAGADOUGOU   (Burkina Faso)

Author keywords

HAART; HIV AIDS; PMTCT; SCART

Indexed keywords

LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE; NEVIRAPINE; ZIDOVUDINE;

ADOLESCENT; ADULT; ARTICLE; BREAST FEEDING; CHILD; COHORT ANALYSIS; DELIVERY; DRUG EFFICACY; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MATERNAL TREATMENT; MONOTHERAPY; PATIENT ASSESSMENT; PREGNANT WOMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROLOGY; SINGLE DRUG DOSE; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BURKINA FASO; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; NEVIRAPINE; PERIPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; YOUNG ADULT; ZIDOVUDINE;

EID: 77954737029     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120903499204     Document Type: Article

References (31)

1. Adeothy-Koumakpaï, S., Monnykosso, C.N., D'almeida, M., Houansou, J., Batossi, G., Hodonou, I., et al. (2004). Prevention of HIV mother to child transmission in Cotonou: Child follow-up. Archives of Pediatrics, 11, 1425-1429.
2. Atashili, J., Kalilani, L., Sejsaria, V., & Sickbert-Bennett, E. (2008). Potential impact of feeding recommendations on mortality and HIV-infection in children born to HIVinfected mothers in Africa: A simulation. BMC Infectious Diseases, 8, 66.
3. Ayouba, A., Tene, G., Cunin, P., & Foupouapouognigni, Y. (2003). Low rate of mother-to-child transmission of HIV-1 after nevirapine intervention in a pilot public heath program in Yaoundé , Cameroun. Journal of AIDS, 34(3), 274-280.
4. Coetzee, D., Hilderband, K., Boulle, A., Drape, B., Abdullah, F., & Goemaere, E. (2005). Effectiveness of the first district-wide program for the prevention of mother-to-child transmission of HIV in South Africa. Bulletin of World Health Organization, 83, 489-494.
5. Cooper, E.R., Charurat, M., Mofenson, L., Hanson, I.C., Pitt, J., Diaz, C., et al. (2002). Combination antiretroviral strategies for the treatment of pregnant HIV-1 infected women and prevention of perinatal HIV-1 transmission. Journal of Acquired Immune Deficiency Syndromes, 29, 484-494.
6. Dabis, F., Msellati, P., Meda, N., Welffens-Ekra, C., You, B., Manigart, O., et al. (1999). 6-months efficacy, tolerance and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfead children in Cote d'Ivoire and Burkina Faso: A double blind placebo controlled multicentre trial. Lancet, 353, 781-785.
7. Dorenbaum, A., Cunningham, C.K., Gelber, R.D., Culnane, M., Mofenson, L., Britto, P., et al. (2002). Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: A randomized trial. JAMA, 288(2), 189-198.
8. Ekouevi, D.K., Coffie, P.A., Becquet, R., Tonwe-Gold, B., Horo, A., Thiebaut, R., et al. (2008). Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Cǒte d'Ivoire. AIDS, 22, 1815-1820.
9. European Collaborative Study Group (2005). Mother-tochild transmission of HIV infection in the era of highly active antiretroviral therapy. Clinical Infectious Diseases, 40, 458-465.
10. Fernandez, R.C., Araujo, L.C., & Medina-Acosta, E. (2005). Prevention of vertical HIV transmission in campos dos Goytacazes, Rio de Janeiro, Brazil. Cadernos de Saúde Pública, 21, 1153-1159.
11. Garcia, P.M., Kalish, L.A., Pitt, J., Minkoff, H., Quinn, T.C., Burchett, S.K., et al. (1999). Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. The New England Journal of Medicine, 341, 441-443.
12. Guay, L.A., Missoke, P., & Fleming, T. (1999). Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET012 randomised trial. Lancet, 345, 795-802.
13. Institut National des Statistiques et de la démographie & ORC Macro (2003). Enquěte démographique et santé au Burkina Faso 2003. Retrieved September, 2009, from http://www.measuredhs.com/countries/ country- main.cfm?ctry-id-50&c-Burkina%20Faso.
14. Jackson, J.B., Musoke, P., & Fleming, T. (2003). Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-Month follow-up of the HIVNET012 randomised trial. Lancet, 362(9387), 859-868.
15. Lallemant, M., Jourdain, G., Le coeur, S., Mary, J.Y., Ngo-Giang-Huong, N., Koetsawang, S., et al. (2004). Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. The New England Journal of Medicine, 351, 217-228.
16. Leroy, V., Sakarovitch, C., & Viho, I. (2007). Acceptability of formula-feeding to prevent HIV postnatal transmission, Abidjan, Cǒte d'Ivoire: ANRS 1201/1202 Ditrame Plus Study. Journal of Acquired Immune Deficiency Syndromes, 44(1), 77-86.
17. Malyuta, R., Newell, M.L., Ostergren, M., Thorne, C., & Zhilka, N. (2006). Prevention of mother-to-child transmission of HIV infection; Ukraine experiment to date. European Journal of Public Health, 16, 123-127.
18. Marrazi, M., Germano, P., Guidotti, G., Bartolo, M., Loureiro, S., Liotta, G., et al. (2006, August 14-18). Impact of HAART administration during pregnancy and breastfeeding on vertical transmission in Sub-Saharan Africa: Results from the DREAM cohort [asbtract]. In XVI international AIDS conference. Toronto, Canada, Abstract No. WEPE0545. Retrieved May 12, 2008, from http://www.iasociety.org/Default.aspx? pageId=11&abstractId=2198673.
19. Musumeci, M., Palano, G.M., Castronuovo, P., Pietra, V., Simproé , J., Musumeci, S., et al. (2007). Human Immunodeficiency Virus Type-1 and cytokines in colostrum from HIV-infected mothers in Burkina Faso. Journal of Infection in Developing Countries, 1(1), 25-29.
20. Nadembega, W.M., Giannella, S., Simporé , J., Ceccherini- Silberstein, F., Pietra, V., Bertoli, A., et al. (2006). Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso. Journal of Medical Virology, 78, 1385-1391.
21. Petra Study Team (2002). Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa and Uganda (Petra Study): A randomised, double-bind, placebo-controlled trial. Lancet, 359(9313), 1178-1186.
22. Shaffer, N. (1999). Short course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: A randomized controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet, 353(9144), 773-780.
23. Simpore, J., Pietra, V., Pignatelli, S., Karou, D., Nadembega, W.M., Ilboudo, D., et al. (2007). Effective program against mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso. Journal of Medical Virology, 79, 873-879.
24. Simpore, J., Pietra, V., Savadogo, A., Pignatelli, S., Nikiema, J.B., Nadembega, W.M., et al. (2006). Reduction of mother-to-child transmission of HIV at Camille Medical Center in Burkina Faso. Journal of Medical Virology, 78, 148-152.
25. Taha, T.E., Kumwenda, N.I., & Gibbons, A. (2003). Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial. Lancet, 362(9391), 1171-1177.
26. Tonwe-Gold, B., Ekouevi, D.K., Viho, I., Amani-Bosse, C., Toure, S., Coffie, P.A., et al. (2007). Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: Evaluation of twotiered approach. PLOS Medicine, 4(8), 1362-1373.
27. Tuomala, R.E., Shapiro, D.E., Mofenson, L.M., Bryson, Y., Culnane, M., Hughes, M.D., et al. (2002). Antiretroviral therapy during pregnancy and the risk of an adverse outcome. New England Journal of Medicine, 346, 1863-1870.
28. UNAIDS (2008). Report on the global AIDS epidemic. Retrieved September 15, 2009, from http://www.un aids.org/en/KnowledgeCentre/HIVData/GlobalReport/ 2008/2008-Global-report.asp.
29. WHO (2005). Antiretroviral drugs and the prevention of mother to child transmission of HIV infection in resource-limited settings. Recommendations for a public health approach (2005 Revision) 28-29 June 2005, Geneva, Switzerland. Retrieved June 19, 2009, from http:// www.who.int/3by5/PMTCTreport-June2005.pdf
30. WHO (2006). Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants in resource-limited settings: Towards universal access. Recommendations for a public health approach. Retrieved February 28, 2007, from http://www.who.int/hiv/pub/ guidelines/pmtct/en/index. html.
31. Wiktor, S.Z., Ekpini, E., & Karon, J.M. (1999). Short course oral zidovudine for prevention of mother-tochild transmission of HIV-1 in Abidjan, Cote d'Ivoire. A randomised trial. Lancet, 353, 781-785.